Association of higher perceived stress and telomere length: stratified analyses
Stratification factor . | n . | Perceived stress . | Difference in telomere length . | . | ||||
---|---|---|---|---|---|---|---|---|
. | . | % moderate, high, or very high stress level . | β* . | 95% CI lower, upper . | ||||
Urinary hormone levels | ||||||||
Epinephrine | ||||||||
Low | 328 | 59 | 210 | −23, 442 | ||||
High | 315 | 54 | −484 | −709, −259 | ||||
Norepinephrine | ||||||||
Low | 322 | 55 | −27 | −263, 208 | ||||
High | 322 | 58 | −246 | −475, −17 | ||||
Dopamine | ||||||||
Low | 327 | 57 | 12 | −230, 254 | ||||
High | 317 | 56 | −257 | −478, −37 | ||||
Cortisol | ||||||||
Low | 319 | 57 | −206 | −441, 29 | ||||
High | 320 | 56 | −101 | −331, 129 | ||||
Major life events/stress | ||||||||
Recent major losses† | ||||||||
0 | 515 | 55 | −73 | −253, 106 | ||||
1 or more | 131 | 61 | −420 | −814, −27 | ||||
Major life losses‡ | ||||||||
0 | 287 | 60 | −143 | −390, 105 | ||||
1 | 280 | 52 | −93 | −349, 163 | ||||
2 or more | 80 | 60 | −146 | −600, 308 | ||||
Familial breast cancer risk§ | ||||||||
1 | 282 | 52 | −2 | −250, 247 | ||||
2 | 263 | 61 | −368 | −635, −102 | ||||
3 or more | 102 | 57 | 101 | −298, 501 | ||||
Demographics and health | ||||||||
Age (y) | ||||||||
Under age 55 | 358 | 59 | −8 | −238, 222 | ||||
55 and older | 289 | 53 | −289 | −519, −59 | ||||
Current marital partnership | ||||||||
Yes | 484 | 57 | −69 | −260, 123 | ||||
No | 163 | 53 | −290 | −594, 15 | ||||
Poor health, cardiovascular disease, or diabetes | ||||||||
No | 519 | 55 | −97 | −273, 80 | ||||
Yes | 128 | 62 | −183 | −594, 227 | ||||
Ever diagnosed with clinical depression | ||||||||
No | 508 | 51 | −87 | −271, 96 | ||||
Yes | 139 | 76 | −216 | −611, 187 |
Stratification factor . | n . | Perceived stress . | Difference in telomere length . | . | ||||
---|---|---|---|---|---|---|---|---|
. | . | % moderate, high, or very high stress level . | β* . | 95% CI lower, upper . | ||||
Urinary hormone levels | ||||||||
Epinephrine | ||||||||
Low | 328 | 59 | 210 | −23, 442 | ||||
High | 315 | 54 | −484 | −709, −259 | ||||
Norepinephrine | ||||||||
Low | 322 | 55 | −27 | −263, 208 | ||||
High | 322 | 58 | −246 | −475, −17 | ||||
Dopamine | ||||||||
Low | 327 | 57 | 12 | −230, 254 | ||||
High | 317 | 56 | −257 | −478, −37 | ||||
Cortisol | ||||||||
Low | 319 | 57 | −206 | −441, 29 | ||||
High | 320 | 56 | −101 | −331, 129 | ||||
Major life events/stress | ||||||||
Recent major losses† | ||||||||
0 | 515 | 55 | −73 | −253, 106 | ||||
1 or more | 131 | 61 | −420 | −814, −27 | ||||
Major life losses‡ | ||||||||
0 | 287 | 60 | −143 | −390, 105 | ||||
1 | 280 | 52 | −93 | −349, 163 | ||||
2 or more | 80 | 60 | −146 | −600, 308 | ||||
Familial breast cancer risk§ | ||||||||
1 | 282 | 52 | −2 | −250, 247 | ||||
2 | 263 | 61 | −368 | −635, −102 | ||||
3 or more | 102 | 57 | 101 | −298, 501 | ||||
Demographics and health | ||||||||
Age (y) | ||||||||
Under age 55 | 358 | 59 | −8 | −238, 222 | ||||
55 and older | 289 | 53 | −289 | −519, −59 | ||||
Current marital partnership | ||||||||
Yes | 484 | 57 | −69 | −260, 123 | ||||
No | 163 | 53 | −290 | −594, 15 | ||||
Poor health, cardiovascular disease, or diabetes | ||||||||
No | 519 | 55 | −97 | −273, 80 | ||||
Yes | 128 | 62 | −183 | −594, 227 | ||||
Ever diagnosed with clinical depression | ||||||||
No | 508 | 51 | −87 | −271, 96 | ||||
Yes | 139 | 76 | −216 | −611, 187 |
Linear regression models with telomere length as outcome for being at or above high-average levels of perceived stress; estimated β coefficient and 95% CIs corresponding to difference in bp average telomere length, adjusting for age and BMI (continuous), non-White race, and smoking history. Stratified using median cut-points for creatinine-adjusted urinary hormones.
Recent major losses, including death of parent, sister, or spouse, divorce, or separation in past 24 mo.
Life losses (premature death of first degree relative), sum of occurrences across categories, including death of a child (any age), death of parent or sibling before age 65 y.
Summation of primary relatives diagnosed with breast cancer + occurrences of diagnoses before age 45 in a mother, sister, or daughter.